75N91022F00010

IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N91022F00010
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL
Source: USASpending (Federal)
Source ID: usa-75N91022F00010

Details

Location: United States

Description

IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL Awarded to: LEIDOS BIOMEDICAL RESEARCH INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication: 2022/07/27 12:00:00 AM UTC
Closing date: 2027/07/26 12:00:00 AM UTC

Estimated value

$16.9M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-02, 1:10:00 a.m.

Data refreshed every 2 hours